NCT06971666Not yet recruiting
Dietary Inflammatory Potential in Young Pleople With Obesity
Relationship Between Dietary Inflammatory Potential, Markers of Inflammation, Microbiota and Risk of Anxiety and Depression in Young People With Obesity
Source: ClinicalTrials.gov · Last updated 14 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The increase in adipose tissue in the young population is one of the most important and worrying public health problems because it persists in adulthood, constituting a risk factor for chronic degenerative diseases with social, economic, and environmental effects. The etiology of obesity is multifactorial and is associated with a low-intensity chronic inflammation process. Therefore, side effects of the digestive, nervous, endocrine, and immunological levels are closely related. Thus, understanding the impact of dietary components on the immune response and the pathophysiological complications of obesity will strengthen information on nutritional patterns with lower inflammatory implications.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 170 (estimated)
- First submitted
- 20 Jan 2025
- Start date
- 20 Jun 2025
- Primary completion date
- 22 Nov 2026
- Lead sponsor
- Instituto Tecnológico y de Estudios Superiores de Occidente
- Diseases
- Obesity
- NCT number
- NCT06971666
What you commit to
- Study type: Observational
- Planned participants: 170
- From 20 Jun 2025 to the primary completion date, 22 Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Significant anticipated changes in diet or exercise within 15 days prior to the study's start
- Participation in any study involving investigational products within the 3 months prior to the start of the study
- Treatment with anti-inflammatory drugs, antibiotics, and/or antidepressants in the month prior to the study's start
- Consumption of nutraceuticals containing prebiotics, probiotics, or immunomodulators within 15 days prior to the study's start
Other illness
- Diagnosed conditions such as: diabetes mellitus, hypertension, renal or hepatic insufficiency, infectious diseases, inflammatory diseases, or any neoplastic disease
- Conditions with dietary restrictions, such as celiac disease or history of gastric bypass surgery
- History of drug or medication abuse
- Eating disorders
Other
- Pregnancy or expected pregnancy within the next month
- Women who are breastfeeding
- Active alcoholism with a daily intake exceeding 50 g/day
- Individuals who choose to discontinue participation after the data collection process has started.
- Individuals who do not consent to the collection of any of the required samples (blood, diet, or stool) during the data collection phase.
Who the study is looking for
- Both sexes with no gender exclusion
- Age between 18 and 24 years
- Body Mass Index (BMI) ≥ 30 kg/m²
- Signed informed consent
Age in the registry: 18 years to 24 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.